10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 490,285 | 473,966 | 432,508 | 397,712 | 377,061 |
| Marketable Securities | 49,563 | 49,443 | 49,576 | 49,549 | 49,844 |
| Receivables | 56,137 | 82,493 | 96,592 | 119,067 | 52,549 |
| Inventories | 53,487 | 56,341 | 61,956 | 68,968 | 74,710 |
| TOTAL | $669,733 | $684,451 | $659,827 | $655,661 | $579,730 |
| Non-Current Assets | |||||
| PPE Net | 220,591 | 226,711 | 232,534 | 239,710 | 246,087 |
| Intangibles | 64,421 | 66,840 | 69,270 | 19,225 | 19,703 |
| Other Non-Current Assets | 61,014 | 63,363 | 65,730 | 65,374 | 57,873 |
| TOTAL | $346,026 | $356,914 | $367,534 | $324,309 | $323,663 |
| Total Assets | $1,015,759 | $1,041,365 | $1,027,361 | $979,970 | $903,393 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,425 | 12,733 | 18,069 | 15,938 | 10,068 |
| Accrued Expenses | 55,186 | 82,471 | 72,850 | 65,165 | 67,440 |
| Other current liabilities | 5,315 | 23,363 | 23,723 | N/A | N/A |
| TOTAL | $113,598 | $153,454 | $147,324 | $112,221 | $107,900 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 24,342 | 23,902 | 22,139 | 21,449 | 20,949 |
| Other Non-Current Liabilities | 77,699 | 81,084 | 84,046 | 83,200 | 76,029 |
| TOTAL | $87,837 | $91,585 | $94,917 | $94,470 | $88,598 |
| Total Liabilities | $201,435 | $245,039 | $242,241 | $206,691 | $196,498 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 126,956 | 127,752 | 126,553 | 124,490 | 123,134 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,524,061 | -1,510,591 | -1,494,339 | -1,466,867 | -1,501,405 |
| Other shareholders' equity | 114 | 225 | 138 | 220 | -367 |
| TOTAL | $814,324 | $796,326 | $785,120 | $773,279 | $706,895 |
| Total Liabilities And Equity | $1,015,759 | $1,041,365 | $1,027,361 | $979,970 | $903,393 |